Fecal Microbiota Transplant for Neuroblastoma in a Single Patient

NO_LONGER_AVAILABLE

Conditions studied: Neuroblastoma, Neuroblastoma (NB), Neuroblastoma (NBL), Neuroblastoma (Measurable Disease), Neuroblastoma Recurrent, Neuroblastoma in Children, Neuroblastoma. CNS

In brief

This study uses fecal microbiota transplant (FMT) to correct gut microbiome dysbiosis prior to and during standard-of-care neuroblastoma treatment

Key facts

Study ID

NCT07223606

Run by

ProgenaBiome

Last updated by the study team

2025-11-03

Who can join

Age: 5 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• willingness of parent/guardian to sign ICF
• diagnosis of neuroblastoma
• dysbiosis of the gut microbiome

You may not qualify if…

• parent/guardian unwilling to sign ICF
• dysbiosis does not show a bifidobaceteria-bacteroides gap
• severely abnormal screening lab values

Where it is running

• ProgenaBiome — Ventura, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.